Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 5c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall Street indexes dip with technology earnings, rising oil in focus
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- Oil settles up more than 3% to six-week high as Mideast conflict threatens oil transit routes
- Can Alphabet earnings reignite investor enthusiasm for the Magnificent Seven?
Avanos Medical (AVNS) PT Raised to $24 at Stifel
July 31, 2024 3:42 PM EDTStifel analyst Rick Wise raised the price target on Avanos Medical (NYSE: AVNS) to $24.00 (from $20.00) while maintaining a Hold rating.
The analyst comments "Avanos delivered a solid 2Q24 performance, as sales and EPS both exceeded our/Consensus estimates. 2024 sales, gross margin, and EPS... More
